ARTICLE | Clinical News

Soriatane acitretin: Phase IV data

March 13, 2006 8:00 AM UTC

Data from an open-label, U.S. and Russian Phase IV trial in 77 evaluable patients showed that long-term use of Soriatane continued to show improvement as measured by OLA at weeks 12 and 24 following a...